Our findings contradict a previous study, which revealed that male HBV carriers are more likely to have BCP mutations, notably the A1762T/G1764A double mutation, and are more likely to develop more severe disease, including cirrhosis or HCC, due to the probable enhancement in HBV replication by testosterone [58,59,60]. This evidence concerns the gene OPN1SW and hepatocellular carcinoma.